About Richter BioLogics
Richter Biologics is a leading, fast-growing German biotechnology company headquartered in Hamburg, specializing in the development and GMP-compliant manufacture of products from microbial expression systems such as bacteria (E.coli) and yeasts (P.Pastoris).
Richter BioLogics offers customized, state-of-the-art solutions at three locations in Hamburg, Hanover and Bovenau. GMP-certified production facilities with production volumes of currently up to 1500 L guarantee flexible production services for biopharmaceutical projects.
By expanding our production capacities, two additional bioreactors with capacities of 300L and 1,500L fermentation volume were added for microbial production.
We offer over 35 years of experience in the development and GMP production of recombinant proteins and peptides, antibody fragments (VHH/Nanobody, Fab fragment), plasmid DNA and vaccines.
We offer our customers from the pharmaceutical and biotechnology industry worldwide flexible and individual solutions for all phases of clinical development - from clinical trial samples to commercial production.
At Richter BioLogics, we are known and valued for our flexibility, high quality services, commitment to good manufacturing practices and complete transparency.
Richter BioLogics works to the highest pharmaceutical quality standards,
which is regularly audited by leading regulatory authorities (e.g. EMA, FDA, PMDA, ANVISA, MFDS) and confirmed in numerous customer audits.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
